CanaFarma In Works to Co-Develop a Bioequivalent of the Anti-COVID19 Drug Hydroxychloroquine
CanaFarma Hemp Products Corp. announced that it is developing a bioequivalent material to...
Read Moreby Abigail Hines | Jun 8, 2020 | Biotech, Canafarma, Cannabis, Corona Cures, Coronavirus, Health, Market News, Markets, Pharmaceutical, Public Companies | 0
CanaFarma Hemp Products Corp. announced that it is developing a bioequivalent material to...
Read Moreby Abigail Hines | May 27, 2020 | Biotech, Canafarma, Cannabis, Health, Hemp, Liquidity, Market News, Markets, Pharmaceutical, Public Companies, Technology | 0
In the past decade, marketing and competition have become an almost unrecognizable picture. The...
Read Moreby Steve Kanaval | May 26, 2020 | Biotech, Canafarma, Cannabis, Coronavirus, Pharmaceutical | 0
Israel’s largest-ever medical-marijuana merger comes via publicly-traded Cannbit...
Read Moreby Steve Kanaval | Apr 14, 2020 | Biotech, Canafarma, Corona Cures, Coronavirus, Mex-Trade Report, Mexican Financial News, Pharmaceutical | 0
Shares in SC Worx (WORX) rallied 424% yesterday after the company revealed orders for $35 million...
Read More